2-{[3-Methyl-4-(2,2,2-trifluoro­eth­oxy)pyridin-2-yl]methyl­sulfan­yl}-1H-benzimidazole monohydrate: a monoclinic polymorph

Autor Chen, Yu-Feng, Chen, Jin-Yao, Hong, Ming-Huang, Lu, Jie, Ren, Guo-Bin
Vydáno 2012

2-{[3-Methyl-4-(2,2,2-trifluoro­eth­oxy)pyridin-2-yl]methyl­sulfan­yl}-1H-benzimidazole propan-2-ol monosolvate: a second monoclinic polymorph

Autor Ma, Jin-Ju, Qi, Ming-Hui, Hong, Ming-Huang, Lu, Jie, Ren, Guo-Bin
Vydáno 2012

2-{[3-Methyl-4-(2,2,2-trifluoro­eth­oxy)pyridin-2-yl]methyl­sulfan­yl}-1H-benzimidazole monohydrate

Autor Ren, Guo-Bin, Hong, Ming-Huang, Zhong, Jia-Liang, Yi, Dong-Xu, Xu, Le-Hui
Vydáno 2011

1,3-Dihy­droxy-2-(hy­droxy­meth­yl)propan-2-aminium formate

Autor Ren, Guo-Bin, Qi, Ming-Hui, Chen, Jin-Yao, Meng, Kun-Yan, Zhong, Jia-Liang
Vydáno 2011

Discovery of potent 2,4-difluoro-linker poly(ADP-ribose) polymerase 1 inhibitors with enhanced water solubility and in vivo anticancer efficacy

Autor Chen, Wen-hua, Song, Shan-shan, Qi, Ming-hui, Huan, Xia-juan, Wang, Ying-qing, Jiang, Hualiang, Ding, Jian, Ren, Guo-bin, Miao, Ze-hong, Li, Jian
Vydáno v Acta Pharmacol Sin (2017)